封面
市場調查報告書
商品編碼
1741519

高溫癌症治療市場按治療類型、應用、最終用戶和地區分類

Hyperthermia Cancer Treatment Market, By Treatment Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年高溫癌症治療市場規模估計為 2.105 億美元,預計到 2032 年將達到 3.186 億美元,2025 年至 2032 年的複合年成長率為 6.1%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 2.105億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年複合年成長率: 6.10% 2032年價值預測 3.186億美元

高溫癌症治療是一種利用熱量治療癌細胞的新型治療方法。高溫療法可以透過外部熱源或直接將熱量引導至腫瘤部位來提高癌細胞的溫度。高溫療法可與其他癌症治療方法(例如化療和放射線治療)合併使用,以增強其療效。

高溫治療將惡性細胞置於高溫下,目的是殺死癌細胞,增強放射治療的有效性,並增加化療藥物的吸收。高溫治療是一種非侵入性治療方法,由於其與傳統治療方法相比,具有改善患者預後並最大程度減少副作用的潛力,在腫瘤學領域正日益受到重視。

市場動態:

預計全球高溫癌症治療市場在預測期內將顯著成長。推動這一成長的市場動態包括多種因素,例如全球癌症盛行率上升、創新癌症治療方法的採用率不斷提高以及技術進步。

全球癌症患者數量的成長是高溫癌症治療市場的主要驅動力之一。根據國際癌症研究機構2021年5月發布的數據,2020年預計新增癌症病例1,930萬例。預計癌症發生率的上升將刺激對包括高溫療法在內的有效治療方案的需求。

此外,熱療設備的技術進步預計將推動市場成長。局部熱療和全身熱療等先進加熱技術的發展,改善了治療效果,拓展了熱療的應用範圍。此外,熱療設備與顯像模式的融合,實現了即時溫度監測和癌細胞的精準靶向,進一步提高了治療效果。

儘管市場潛力巨大,但某些因素可能會抑制其成長。例如,醫護人員和病患對高溫治療的認知度較低、治療費用高昂、以及報銷困難等,都是阻礙市場擴張的一些因素。然而,提高認知度、優惠的報銷政策以及持續的研發活動有望克服這些挑戰。

本研究的主要特點

  • 本報告對全球高溫癌症治療市場進行了詳細分析,並提供了預測期 2025-2032 的市場規模和複合年成長率(CAGR,%),以 2024 年為基準年。
  • 它還強調了各個領域的潛在商機,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 本研究報告針對該產業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球高溫癌症治療市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 全球癌症發生率正在上升
  • 熱療系統高成本
  • 奈米粒子介導的熱療越來越受歡迎
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

第4章 高溫癌症治療市場-冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年高溫癌症治療市場(依治療類型)

  • 局部高溫
  • 局部高溫
  • 全身熱療

6. 2020 年至 2032 年高溫癌症治療市場(依應用)

  • 攝護腺癌
  • 乳癌
  • 子宮頸癌
  • 皮膚癌
  • 其他癌症

7. 2020 年至 2032 年熱療癌症治療市場(依最終使用者分類)

  • 醫院
  • 診所
  • 專業中心
  • 其他(學術研究機構)

8. 2020 年至 2032 年熱療癌症治療市場(按地區)

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韓國
      • 其他亞太地區
  • 中東
      • GCC
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第9章 競爭態勢

  • MagForce AG
  • Andromedic Srl
  • Celsius42 GmbH
  • Oncotherm Kft
  • Pyrexar Medical
  • YAMAMOTO VINITA CO.,LTD
  • Nanoprobes
  • Alba Hyperthermia System
  • Novavida
  • Sensius

第 10 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6415

Hyperthermia Cancer Treatment Market is estimated to be valued at USD 210.5 Mn in 2025 and is expected to reach USD 318.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 210.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.10% 2032 Value Projection: USD 318.6 Mn

Hyperthermia cancer treatment is a novel therapeutic approach that utilizes heat to treat cancer cells. It involves raising the temperature of cancerous cells, either from external sources or by directing heat specifically to the tumor site. Hyperthermia can be used in conjunction with other cancer treatments like chemotherapy and radiation therapy to improve their efficacy.

By subjecting malignant cells to higher temperatures, hyperthermia treatment aims to kill cancer cells, enhance the effectiveness of radiation therapy, and increase the uptake of chemotherapeutic agents. It is a non-invasive method that is gaining momentum in the field of oncology due to its potential to improve patient outcomes and minimize side effects compared to traditional treatments.

Market Dynamics:

The global hyperthermia cancer treatment market is expected to experience significant growth during the forecast period. The market dynamics driving this growth include various factors such as the rising prevalence of cancer worldwide, increasing adoption of innovative cancer treatment methods, and advancements in technology.

Rising cases of cancer globally is one of the key drivers of the Hyperthermia cancer treatment market. According to the data published by the International Agency for Research on Cancer in May 2021, an estimated 19.3 million new cancer cases occurred in 2020. This growing incidence of cancer is expected to fuel demand for effective treatment options, including hyperthermia therapy.

Moreover, technological advancements in hyperthermia treatment devices are expected to propel market growth. The development of advanced heating techniques, such as regional and whole-body hyperthermia, has improved treatment outcomes and expanded the applicability of hyperthermia therapy. Additionally, the integration of hyperthermia devices with imaging modalities allows for real-time temperature monitoring and precise targeting of tumor cells, further enhancing treatment efficacy.

While the market holds immense potential, certain factors may restrain its growth. Limited awareness about hyperthermia treatment among healthcare professionals and patients, high treatment costs, and reimbursement challenges are some of the obstacles that may hinder market expansion. However, efforts to increase awareness, favorable reimbursement policies, and ongoing research and development activities are expected to overcome these challenges.

Key Features of the Study:

  • This report provides in-depth analysis of the global hyperthermia cancer treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR, %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key companies covered as a part of this study include MagForce AG, Andromedic S.r.l., Celsius42 GmbH, Oncotherm Kft, Pyrexar Medical, YAMAMOTO VINITA CO.,LTD, Nanoprobes, Alba Hyperthermia System, Novavida, and Sensius.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgradation, market expansion, and marketing tactics.
  • The global hyperthermia cancer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hyperthermia cancer treatment market

Hyperthermia Cancer Treatment Market Detailed Segmentation:

  • By Treatment Type:
    • Local Hyperthermia
    • Regional Hyperthermia
    • Whole Body Hyperthermia
  • By Application:
    • Prostate Cancer
    • Breast Cancer
    • Cervical Cancer
    • Skin Cancer
    • Other Cancers
  • By End User:
    • Hospitals
    • Clinic
    • Specialty Centres
    • Others (Academic and Research Institute)
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • MagForce AG
    • Andromedic S.r.l.
    • Celsius42 GmbH
    • Oncotherm Kft
    • Pyrexar Medical
    • YAMAMOTO VINITA CO.,LTD
    • Nanoprobes
    • Alba Hyperthermia System
    • Novavida
    • Sensius

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Hyperthermia Cancer Treatment Market, By Treatment Type
    • Global Hyperthermia Cancer Treatment Market, By Application
    • Global Hyperthermia Cancer Treatment Market, By End User
    • Global Hyperthermia Cancer Treatment Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of cancer worldwide
    • Restraints
  • High costs of hyperthermia systems
    • Opportunities
  • Growing popularity of nanoparticle-mediated hyperthermia
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Hyperthermia Cancer Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Hyperthermia Cancer Treatment Market , By Treatment Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Local Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Regional Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Whole Body Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Hyperthermia Cancer Treatment Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cervical Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Skin Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Other Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Hyperthermia Cancer Treatment Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Clinic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Specialty Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Academic and Research Institute)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Hyperthermia Cancer Treatment Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • MagForce AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Andromedic S.r.l.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celsius42 GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Oncotherm Kft
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pyrexar Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • YAMAMOTO VINITA CO.,LTD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nanoprobes
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alba Hyperthermia System
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novavida
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sensius
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us